Rice Hall James & Associates, LLC Ascendis Pharma A/S Transaction History

Rice Hall James & Associates, LLC

$1.69 Billion
Q3 2024

A detailed history of Rice Hall James & Associates, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 160,614 shares of ASND stock, worth $20.7 Million. This represents 1.42% of its overall portfolio holdings.

Number of Shares

160,614

Previous 151,656 5.91%

Holding current value

$20.7 Million

Previous $20.7 Million 15.98%

% of portfolio

1.42%

Previous 1.35%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$113.0 - $153.43 $1.01 Million - $1.37 Million	8,958 Added 5.91%	160,614 $24 Million
Q2 2024 Aug 07, 2024	SELL	$121.07 - $153.67 $1.3 Million - $1.65 Million	-10,756 Reduced 6.62%	151,656 $20.7 Million
Q1 2024 Apr 23, 2024	SELL	$123.45 - $159.4 $798,844 - $1.03 Million	-6,471 Reduced 3.83%	162,412 $24.6 Million
Q4 2023 Feb 08, 2024	SELL	$86.1 - $127.36 $77,834 - $115,133	-904 Reduced 0.53%	168,883 $21.3 Million
Q3 2023 Nov 02, 2023	SELL	$86.5 - $103.97 $317,974 - $382,193	-3,676 Reduced 2.12%	169,787 $15.9 Million
Q2 2023 Jul 24, 2023	BUY	$69.96 - $97.84 $1.3 Million - $1.81 Million	18,535 Added 11.96%	173,463 $15.5 Million
Q1 2023 May 11, 2023	BUY	$104.9 - $126.78 $963,926 - $1.16 Million	9,189 Added 6.31%	154,928 $16.6 Million
Q4 2022 Jan 27, 2023	BUY	$99.42 - $131.97 $924,009 - $1.23 Million	9,294 Added 6.81%	145,739 $0
Q3 2022 Nov 01, 2022	SELL	$84.03 - $110.23 $2.23 Million - $2.93 Million	-26,543 Reduced 16.29%	136,445 $14.1 Million
Q2 2022 Aug 08, 2022	BUY	$78.08 - $117.61 $2.19 Million - $3.3 Million	28,088 Added 20.82%	162,988 $15.2 Million
Q1 2022 May 05, 2022	BUY	$102.18 - $135.75 $3.58 Million - $4.76 Million	35,039 Added 35.09%	134,900 $15.8 Million
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $2.94 Million - $3.92 Million	23,095 Added 30.08%	99,861 $13.4 Million
Q3 2021 Nov 09, 2021	BUY	$112.67 - $176.92 $4.12 Million - $6.47 Million	36,593 Added 91.09%	76,766 $12.2 Million
Q1 2021 May 14, 2021	SELL	$124.92 - $173.33 $226,105 - $313,727	-1,810 Reduced 4.31%	40,173 $5.18 Million
Q4 2020 Feb 16, 2021	BUY	$151.2 - $182.76 $2.98 Million - $3.6 Million	19,696 Added 88.37%	41,983 $7 Million
Q3 2020 Nov 16, 2020	BUY	$134.29 - $154.32 $2.99 Million - $3.44 Million	22,287 New	22,287 $3.44 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.21B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account

Rice Hall James & Associates, LLC Ascendis Pharma A/S Transaction History